• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GRTX

GRTX

Galera Therapeutics, Inc.

OTCHealthcareBiotechnologyUS

USD0.10

-0.00 (-0.99%)

Rating:A

Company Profile

CEO

J. Mel Sorensen

IPO Date

2019-11-07

Sector

Healthcare

Industry

Biotechnology

Exchange

OTC

Country

US

Market Metrics

Open

$0.10

Prev. Close

$0.10

Day Low

$0.10

Day High

$0.10

52W Low

$0.01

52W High

$0.15

Market Cap

$0.01B

Volume

0.01M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

41.6%

Avg Negative

1.4%

Avg Neutral

57.1%

News Feed

Galera Announces Completion of Enrollment in Pivotal 455-Patient Phase 3 Trial of Avasopasem for Severe Oral Mucositis

GlobeNewsWire·6/28/2021·↓ negative

Galera Announces First Patient Dosed with GC4711 in Phase 2b GRECO-2 Trial in Patients with Pancreatic Cancer

GlobeNewsWire·5/17/2021·↑ positive

Galera to Participate in the BofA Securities 2021 Virtual Healthcare Conference

GlobeNewsWire·5/5/2021·↑ positive

GRTX Stock: From $6.61 To Over $8.80 Pre-Market Explanation

Pulse2·4/29/2021·↑ positive

Galera Announces Updated Data from its Randomized, Multicenter, Placebo-Controlled Trial in Patients with Pancreatic Cancer

GlobeNewsWire·4/28/2021·↑ positive

Galera Therapeutics to Present at the Oppenheimer 31st Annual Healthcare Conference

GlobeNewsWire·3/10/2021·↑ positive

Galera Therapeutics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

GlobeNewsWire·11/20/2020·↑ positive

Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates

GlobeNewsWire·11/10/2020·↑ positive

Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference

GlobeNewsWire·11/3/2020·↑ positive

Galera Therapeutics Announces Interim Data from Pilot Phase 1/2 Trial of GC4419 in Combination with Stereotactic Body Radiation Therapy Showed Improved Overall Survival in Patients with Locally Advanced Pancreatic Cancer

GlobeNewsWire·10/27/2020·↑ positive